Genital Herpes Vaccine - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Genital Herpes Vaccine Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Genital Herpes Vaccine Market Restraints
Table 3. Genital Herpes Vaccine Market Trends
Table 4. Genital Herpes Vaccine Industry Policy
Table 5. Global Genital Herpes Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Genital Herpes Vaccine Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Genital Herpes Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Genital Herpes Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Genital Herpes Vaccine Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Genital Herpes Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Genital Herpes Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Genital Herpes Vaccine Manufacturers Product Type
Table 13. Head Office and Genital Herpes Vaccine Production Site of Key Manufacturer
Table 14. Genital Herpes Vaccine Capacity of Major Manufacturers and Future Plan
Table 15. China Genital Herpes Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Genital Herpes Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Genital Herpes Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Genital Herpes Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Genital Herpes Vaccine Production by Region, 2018-2023, (K Units)
Table 20. Global Genital Herpes Vaccine Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Genital Herpes Vaccine Upstream (Raw Materials)
Table 22. Global Genital Herpes Vaccine Typical Customers
Table 23. Genital Herpes Vaccine Typical Distributors
Table 24. By Type, Global Genital Herpes Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Genital Herpes Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Genital Herpes Vaccine Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Genital Herpes Vaccine Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Genital Herpes Vaccine Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Genital Herpes Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Genital Herpes Vaccine Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Genital Herpes Vaccine Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Genital Herpes Vaccine Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Genital Herpes Vaccine Sales Quantity Market Share, 2018-2029
Table 34. GSK Company Information, Head Office, Market Area, and Industry Position
Table 35. GSK Genital Herpes Vaccine Models, Specifications, and Application
Table 36. GSK Genital Herpes Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. GSK Company Profile and Main Business
Table 38. GSK Recent Developments
Table 39. Merck Company Information, Head Office, Market Area, and Industry Position
Table 40. Merck Genital Herpes Vaccine Models, Specifications, and Application
Table 41. Merck Genital Herpes Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Merck Company Profile and Main Business
Table 43. Merck Recent Developments
Table 44. BioNTech Company Information, Head Office, Market Area, and Industry Position
Table 45. BioNTech Genital Herpes Vaccine Models, Specifications, and Application
Table 46. BioNTech Genital Herpes Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. BioNTech Company Profile and Main Business
Table 48. BioNTech Recent Developments
Table 49. Beike Bio Company Information, Head Office, Market Area, and Industry Position
Table 50. Beike Bio Genital Herpes Vaccine Models, Specifications, and Application
Table 51. Beike Bio Genital Herpes Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Beike Bio Company Profile and Main Business
Table 53. Beike Bio Recent Developments
Table 54. Changsheng Biotechnology Company Information, Head Office, Market Area, and Industry Position
Table 55. Changsheng Biotechnology Genital Herpes Vaccine Models, Specifications, and Application
Table 56. Changsheng Biotechnology Genital Herpes Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Changsheng Biotechnology Company Profile and Main Business
Table 58. Changsheng Biotechnology Recent Developments
List of Figures
Figure 1. Genital Herpes Vaccine Picture
Figure 2. Global Genital Herpes Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Genital Herpes Vaccine Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Genital Herpes Vaccine Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Genital Herpes Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Genital Herpes Vaccine Sales Quantity (K Units) & (2018-2029)
Figure 7. China Genital Herpes Vaccine Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Genital Herpes Vaccine Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Genital Herpes Vaccine Market Share of Global, 2018-2029
Figure 10. Global Genital Herpes Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Genital Herpes Vaccine Key Participants, Market Share, 2022
Figure 12. Global Genital Herpes Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Genital Herpes Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Genital Herpes Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 15. Genital Herpes Vaccine Industry Chain
Figure 16. Genital Herpes Vaccine Procurement Model
Figure 17. Genital Herpes Vaccine Sales Model
Figure 18. Genital Herpes Vaccine Sales Channels, Direct Sales, and Distribution
Figure 19. Zoster Vaccine Live
Figure 20. Recombinant Zoster Vaccine
Figure 21. By Type, Global Genital Herpes Vaccine Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Genital Herpes Vaccine Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Genital Herpes Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Genital Herpes Vaccine Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Genital Herpes Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Male
Figure 27. Female
Figure 28. By Application, Global Genital Herpes Vaccine Consumption Value, 2018-2029, US$ Million
Figure 29. By Application, Global Genital Herpes Vaccine Consumption Value Market Share, 2018-2029
Figure 30. By Application, Global Genital Herpes Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 31. By Application, Global Genital Herpes Vaccine Sales Quantity Market Share, 2018-2029
Figure 32. By Application, Global Genital Herpes Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 33. By Region, Global Genital Herpes Vaccine Consumption Value Market Share, 2018-2029
Figure 34. By Region, Global Genital Herpes Vaccine Sales Quantity Market Share, 2018-2029
Figure 35. North America Genital Herpes Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 36. By Country, North America Genital Herpes Vaccine Consumption Value Market Share, 2022
Figure 37. Europe Genital Herpes Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, Europe Genital Herpes Vaccine Consumption Value Market Share, 2022
Figure 39. Asia Pacific Genital Herpes Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country/Region, Asia Pacific Genital Herpes Vaccine Consumption Value Market Share, 2022
Figure 41. South America Genital Herpes Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, South America Genital Herpes Vaccine Consumption Value Market Share, 2022
Figure 43. Middle East & Africa Genital Herpes Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. U.S. Genital Herpes Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 45. By Type, U.S. Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 46. By Application, U.S. Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 47. Europe Genital Herpes Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, Europe Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, Europe Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 50. China Genital Herpes Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, China Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, China Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 53. Japan Genital Herpes Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, Japan Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, Japan Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 56. South Korea Genital Herpes Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, South Korea Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, South Korea Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 59. Southeast Asia Genital Herpes Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, Southeast Asia Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, Southeast Asia Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 62. India Genital Herpes Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, India Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, India Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 65. Middle East & Africa Genital Herpes Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, Middle East & Africa Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, Middle East & Africa Genital Herpes Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 68. Research Methodology
Figure 69. Breakdown of Primary Interviews
Figure 70. Bottom-up and Top-down Approaches
Figure 71. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets